| 2.66 Real-Time Quote |  -0.64 / -19.39%Today’s Change | 1.89 Today|||52-Week Range 3.63 | +33.67% Year-to-Date |
| Previous close | 3.30 |
| Today’s open | 2.80 |
| Day’s range | 2.59 - 2.80 |
| Volume | 4,381,273 |
| Average volume (3 months) | 206,277 |
| Market cap | $100.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -28.89% |
| Earnings growth (this year) | +43.01% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +105.21% |
| P/E ratio | NM |
| Price/Sales | 6.49 |
| Price/Book | 14.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| BOTABiota Pharmaceutical... | -0.07 | -1.90% |
| ATHXAthersys Inc | -0.04 | -2.15% |
| NWBONorthwest Biotherape... | +0.08 | +2.24% |
| ACURAcura Pharmaceutical... | -0.00 | -0.09% |
| Last reporting date | May 13, 2013 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $8.4M |
| Annual profit (last year) | -$31.8M |
| Net profit margin | -303.71% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Richard W. Pascoe |
Chief Financial Officer & Senior Vice President Steven Robert Martin, CPA |
Corporate headquarters San Diego, California |
.
